-
While surgery is the most accepted method for treating ovarian endometriomas, recurrence often is recorded. Results from newly published research, which evaluates use of cyclic and continuous administration of oral contraceptives post surgical removal, indicate that Pill use can effectively reduce and delay endometrioma recurrence.
-
Signs have been pointing toward a renaissance for intrauterine devices (IUDs). Since 2005, IUD use has gone up by 161%, according to SDI Health, a health care analytics firm in Plymouth Meeting, PA.
-
The Agency for Healthcare Research and Quality (AHRQ) has issued a notice about its expectations with the completion of grants awarded from the funding provided by the American Reinvestment and Recovery Act (ARRA). Among the key points:
-
With the creation of the Clinical and Translational Science Awards (CTSA) program, the goal of involving the community in research has drawn more support and interest.
-
Adaptive design clinical trials raise many of the same issues in IRB review as do unplanned modifications to existing trials, says Marjorie Speers, PhD, executive director of the Association for the Accreditation of Human Research Protection Programs (AAHRPP) in Washington DC.
-
As Americans become increasingly accustomed to learning more about their own health, it's becoming more common for research participants to expect to learn about their personal results during a study.
-
For researchers and IRBs there is an ethical paradox in behavioral studies involving populations that are hard to engage.
-
This is the second of a two-part series examining some of the regulatory and financial changes faced by hospices during recent years.
-
The ideal time for a patient to learn about the potential need to deactivate the electrical shock feature of an implantable cardioverter-defibrillator (ICD) is when the decision to implant the device is made, says Chuck Wellman, MD, FAAHPM, chief medical officer at Hospice of the Western Reserve in Cleveland, OH.
-